7 5 月, 2021

X World Games Secures $1.2 Million Funding led by Top Crypto Venture Funds

Singapore / SEAPRWire / May 7, 2021 / - The X World Games (XWG) is excited to announce a $1.2M funding from institutional investors, including NGC, FBG Capital, Longling Capital, SNZ, Moonwhale Ventures, AU21,Kyros Ventures and BTX Capital. This investment funding marks a critical milestone in XWG's initial stage. The X World Games is a decentralized gaming ecosystem built on the Binance Smart Chain. Players can create, tokenize and trade customized in-game items with the ability to socialize with other crypto gaming communities. Dream Card is the first blockchain trading card game on the X World Games platform using Non-Fungible Token. Gamers can obtain different ACG character cards and customize them with unique equipment, making the game more interesting and creative. "X World Games is featured with low gas fees, fast-minting ability, and decentralized governance, providing a one-stop solution for blockchain gamers, and we are very amazed with this project.", said the investor of LongLing Capital, a digital asset firm with AUM over 2 Billion. "With our due diligence, we found X World Games already built a huge existing global-community base and had mature experience in NFT-gaming developing." said the investor from FBG Capital, a top digital asset firm in the blockchain-based market. The traditional gaming industry is facing a tricky problem - inflation from the in-game economy, which leads to an unfriendly gaming experience. However, NFT can perfectly solve this issue based on its traits of indivisibility, irreplaceability, and uniqueness. Fernando Liu, the CEO of X World Games, believes that NFT will provide a whole new era to the gaming industry, especially in decentralized gaming economics, with a more fair, balanced, and diversified ecosystem. ''X World Games' goal is to build a new blockchain game-based ecosystem, including NFT exchange, cross-chain bridge mechanism, DeFi swap & staking, and a game metaverse of creation and play. It will be more like a social network than just a gaming platform." added Erick, the CMO of X World Games. The Dream Card game was initiated in 2019, inspired by the successful Pokemon Trading Card Game. Its former version of the game, Belle Battle Musou, has been available on iOS and android since 2017. According to taptap.com, Belle Battle Musou has over 300,000 gamers in the global community and more than 60 million card owners, which placed a stepping-stone for X World Games' successful launch. The XWG team is committed to creating a new ecosystem where crypto and non-crypto gamers can create and play their games, and there will be more games to launch in the near future. To get more information about X World Games, please follow X World Games on social channels. Social Links Twitter: https://twitter.com/xwg_games Telegram: https://t.me/xworldgames Medium: https://xwg-games.medium.com Media Contact Company: X World Games Contact: Ada Yuan, COO Website: https://xwg.games/ Twitter: https://twitter.com/xwg_games?s=21 SOURCE: X World Games The article is provided by a third-party content provider. SEAPRWire ( www.seaprwire.com ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Indonesia, Thailand, Vietnam, Singapore, Malaysia, Philippines & Hong Kong )

7 5 月, 2021

ACDX Offers World’s First Leveraged Trading for Chia (XCH)

Seychelles, May 7, 2021 - (ACN Newswire via SEAPRWire.com) - ACDX, the crypto derivatives exchange offering advanced structured products for sophisticated traders, is offering their users with the world's first leveraged BBS trading option for Chia Tokens (XCH). It is the world's first crypto exchange to kick off such leveraged listing, empowering users to trade XCH Bull Bear Strike Token (XCH BBS) with multiple times leverage.Founded by Bram Cohen, the inventor of the BitTorrent network, Chia Network is building a better blockchain and smart transaction platform which is more decentralized, more efficient, and more secure. It is the first enterprise-grade digital money, using the first new Nakamoto consensus algorithm since Bitcoin. Their goal is to improve the global financial and payments system."We are always looking for innovative, secure, and efficient projects to list on ACDX. Chia Network is exactly what we are seeking," commented Andy Cheung, founder and executive chairman of ACDX.ACDX is a next-generation crypto exchange that strives to architect innovations into the crypto market. Designed by professional traders, their most unique product is Bull Bear Strike Token (BBS) that combines the fascination of perpetual futures and options. It can be traded as easy as perpetual futures with the capped risk like options.Given the mass adoption of blockchain this year, ACDX has decided to reaffirm their commitment to the global decentralized financial economy. As Chia is adopting more modern cryptographic tools to enable richer smart transaction capabilities, ACDX believes the listing can help them deliver the vision to bridge the gap between the decentralized and centralized blockchain economy."We have been closely monitoring the decentralized financial space. Our team is aware that many financial and payments projects have flourished in 2021 with the potential to blossom further in 2022. PayPal, eBay, etc. To respond to our community's need, we decide to explore this field." commented Andy Cheung.About ACDXACDX offers a next-generation cryptocurrency derivatives trading platform with cryptocurrency structured products. The exchange is focused on true innovation across a wide range of easy-to-use, fair, and transparent trading products that suit the needs of current and emerging cryptocurrency traders. Copyright 2021 ACN Newswire. All rights reserved. (via SEAPRWire)

22 4 月, 2021

Avance Clinical Invited to Present “Decentralized Trials – No Going Back” for Oracle Health Sciences Connect

ADELAIDE, AU, Apr 22, 2021 - (ACN Newswire via SEAPRWire.com) - The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on the future of decentralized clinical trials at the Oracle Health Sciences Connect conference.Title: Decentralized Trials - No Going BackLink: https://www.oracle.com/in/industries/life-sciences/health-sciences-connect/sessions/ Time: 23 April, 2021 - 3.05 pm (Australia/Adelaide ACST).Avance Clinical CEO Yvonne Lungershausen, shared the company's insights on the future of Decentralized Clinical Trials (DCTs) and the technology and patient factors that will determine success. Avance Clinical uses the full range of eClincial technologies to support clients wanting DCTs or a site-based approach while still leveraging advance technology including ePro, eSource and eConsent."DCTs are fast becoming the new norm and this is an incredible opportunity for the drug development sector as well as the diverse and remote patient populations that will now have access to clinical trials," said Lungershausen. "The pandemic has been the catalyst in speeding up the adoption of decentralised clinical trial methods, as people stopped participating in trials and visiting clinics. Trials have stalled putting lives and significant investments at risk."Yvonne Lungershausen said there are considerable benefits to DCT's including:- Reduce the scheduling and travel burden on patients - providing care from the comfort of the patient's home.- Connecting patients to trials on a global scale - patients that were otherwise inaccessible under more traditional trial protocols are now available.And she said challenges include:- Missed human-to-human contact and continuity of patient care- Investigational product distribution to more remote destinations- Oversight of compliance and study procedures in the patient's homeThe presentation also covers advances in artificial intelligence (AI), machine learning, cloud computing and blood self-collection devices which are all revolutionising the decentralized clinical trial process.- Wearable devices are demonstrating enormous potential whether worn as a wrist strap or an adhesive patch on the body. AI-embedded capabilities allow these devices to measure a patient's heart rate or metabolism remotely. Linked to the cloud through secure networks, clinicians can receive and analyse the data real-time.- Video calling and electronic reminders, can improve patient compliance in trials - prompting participants to take their medication at the right time or to record in their electronic diary development.- Technologies are developing to allow patient-centric sampling (self-collection of specimens) with devices that require the use of a lancet and finger prick whereas others do not, making clinical trials even more convenient.Take the Quiz - Test your Knowledge about Australian Clinical Trials here:https://www.surveymonkey.com/r/Australian-Clinical-TrialsAbout Avance ClinicalAustralia's Avance Clinical has more than 20-years of experience and is now one of Australia's leading Contract Research Organizations. Avance Clinical facilitates quality drug development by aligning people, skills, and expertise in the pursuit of drug development for a healthier world.Avance Clinical is committed to providing high-quality clinical research services with its highly experienced team. The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of experts who also demonstrate passion in their chosen field. Avance Clinical offers high-quality services in an established clinical trial ecosystem, that includes world-class Investigators and Sites able to access specialized patient groups. Learn more at http://www.avancecro.com.Other benefits include:1. The Government R&D grant means up to 43.5% rebate on clinical trial spend2. Telehealth pivot during COVID-19 pandemic - speed and continuity3. Site Initiation Visit (SIV) and Study Start achieved in 5-6 weeks4. No IND required for clinical trials5. Full GMP material is not mandated for Phase I clinical trials6. Established clinical trial environment with world-class Investigators and sites7. Established healthy subject databases and specialized patient populations8. Five independent Phase 1 facilities across Australia including hospital-based units for critical care9. Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with a long track-record in FDA compliant research10. Seasonal studies: Northern hemisphere Sponsors can conduct their studies year-round by taking advantage of Australia's counter-flu and allergy seasonsMedia Contact: media@avancecro.com Copyright 2021 ACN Newswire. All rights reserved. (via SEAPRWire)